Indicators

Markets:

News

Latest News about REPL

Recent news which mentions REPL

< Previous 1 2 3 Next >

8 Health Care Stocks Whale Activity In Today's Session

November 07, 2023

The Latest Analyst Ratings for Replimune Group

August 01, 2023

Analyst Ratings for Replimune Group

June 07, 2023

12 Health Care Stocks Moving In Monday's Intraday Session

June 05, 2023

Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session

June 05, 2023

Recap: Replimune Group Q4 Earnings

May 18, 2023

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month

April 13, 2023

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023

January 05, 2023

Analyst Beefs Up Replimune Price Target As Recent Data Validates Treatment Platform

December 12, 2022

PayPal To Rally Around 47%? Here Are 10 Other Price Target Changes For Monday

December 12, 2022

Analyst Ratings for Replimune Group

December 07, 2022

Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session

December 07, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session

December 07, 2022

Replimune Shares Surge After Early Data From Pretreated Melanoma Patients

December 07, 2022

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

December 07, 2022

Replimune Group: Q2 Earnings Insights

November 03, 2022

Replimune Gets 33% Price Target Bump Ahead Of Upcoming Readouts. Analyst Lists The Catalysts

October 14, 2022

Wells Fargo To Surge Around 20%? Here Are 5 Other Price Target Changes For Monday

October 03, 2022

Billionaires Are Scooping Up These 3 Beaten-Down Biotech Stocks

August 24, 2022

PreMarket Prep: Looking For Biotech Bargains With This Wedbush Analyst

May 25, 2022

Analyst Ratings for Replimune Group

May 24, 2022

Replimune Group: Q4 Earnings Insights

May 19, 2022

The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict

March 30, 2022

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More

March 27, 2022

Stocks That Hit 52-Week Lows On Friday

February 18, 2022

Replimune Group: Q3 Earnings Insights

February 03, 2022

The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program

February 01, 2022

Stocks That Hit 52-Week Lows On Thursday

January 20, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021

November 19, 2021

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More

November 08, 2021

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.